LOCAL PROVIDER DIRECTORY
Find a dentist
Search by name or specialty, then choose a city and region or enter a ZIP / postal code.
Choose a location to keep your results local.
Local Health Alerts
Why the FDA’s trial-results push matters for patients and readers
The FDA is pressing more than 2,200 sponsors and researchers to post required clinical trial results to ClinicalTrials.gov. For patients and readers, the issue is simple: missing results can distort what we think works, what does not, and how safe a medical product…
Long COVID fatigue study raises interest in fluvoxamine, not a new standard
A new randomized trial found a signal that fluvoxamine may ease long COVID fatigue, but the evidence is still early and does not change routine care yet. CDC guidance says there are no approved tests or treatments for Long COVID, and treatment remains…
Postpartum diabetes testing after gestational diabetes: what the trial found
A randomized trial suggests that moving the postpartum glucose test to the hospital stay may help more people with gestational diabetes complete screening. The result points to a practical problem: after delivery, follow-up testing can fail because of logistics, not just motivation.
Can fluvoxamine help long COVID fatigue? Early trial results show a possible signal, but it is not practice-changing
A new randomized study suggests fluvoxamine may ease long COVID fatigue for some people, but the finding is narrow, early, and not enough to change routine care. CDC guidance still says long COVID is diagnosed clinically, there is no approved test, and treatment…
FDA’s March 2026 rare-disease approvals: what families should know
Three FDA decisions in March 2026 gave families in the rare-disease world something unusual: approved options for conditions that previously had few or none. Here’s what changed, what the evidence looked like, and what still needs to be watched closely.
RSV vaccine in pregnancy: what parents of newborns should know
There are two main ways to help protect babies from severe RSV: maternal vaccination during a narrow pregnancy window, or an infant RSV monoclonal antibody after birth. CDC says the right option depends on timing, eligibility, and whether a mother already received RSV…
FDA pushes better pregnancy safety data for medicines
The FDA has issued new guidance aimed at improving how pregnancy safety data are collected for drugs and biologics. For patients, the practical takeaway is not that treatment rules changed today, but that the evidence base for medicine use in pregnancy may become…
CDC’s March 2026 kidney disease update supports earlier screening
New CDC estimates show chronic kidney disease remains common in the U.S. and often goes unnoticed. Adults with diabetes, high blood pressure, heart disease, or a family history of kidney disease may have the most to gain from earlier screening and follow-up in…
Breast Screening Debate Heats Up as U.S. Guidance Stands
Breast cancer screening is back in the news because policy leaders and researchers are revisiting how mammograms should be recommended and covered. For most average-risk U.S. women, the practical advice has not changed: keep following current screening guidance and confirm your schedule with…
FDA Pushes Faster Trial Reporting as NIH Updates Its Rules
The FDA is pressing sponsors and researchers to report clinical trial results on time, saying missing data can distort what doctors and patients think they know. A new FDA push and an NIH policy update are raising the stakes for transparency as the…
FDA expands Enhertu use in early HER2-positive breast cancer
The FDA’s May 15 approval adds two early-stage breast cancer uses for Enhertu, also known as fam-trastuzumab deruxtecan-nxki. The update matters for some adults with HER2-positive disease, but it does not change screening guidance or replace a discussion about surgery, chemotherapy, and other…
New trial finds patient navigation may help after a positive FIT
A new randomized clinical trial suggests centralized patient navigation can help people get a follow-up colonoscopy sooner after a positive FIT stool test. The finding matters because a FIT is a screening step, not the endpoint: an abnormal result still needs diagnostic follow-up.